133 related articles for article (PubMed ID: 17971125)
1. Protective up-regulation of CK2 by mutant huntingtin in cells co-expressing NMDA receptors.
Fan MM; Zhang H; Hayden MR; Pelech SL; Raymond LA
J Neurochem; 2008 Feb; 104(3):790-805. PubMed ID: 17971125
[TBL] [Abstract][Full Text] [Related]
2. Mutant huntingtin enhances excitotoxic cell death.
Zeron MM; Chen N; Moshaver A; Lee AT; Wellington CL; Hayden MR; Raymond LA
Mol Cell Neurosci; 2001 Jan; 17(1):41-53. PubMed ID: 11161468
[TBL] [Abstract][Full Text] [Related]
3. P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.
Fan J; Gladding CM; Wang L; Zhang LY; Kaufman AM; Milnerwood AJ; Raymond LA
Neurobiol Dis; 2012 Mar; 45(3):999-1009. PubMed ID: 22198502
[TBL] [Abstract][Full Text] [Related]
4. Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease.
Fan J; Cowan CM; Zhang LY; Hayden MR; Raymond LA
J Neurosci; 2009 Sep; 29(35):10928-38. PubMed ID: 19726651
[TBL] [Abstract][Full Text] [Related]
5. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
[TBL] [Abstract][Full Text] [Related]
6. Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity.
Cowan CM; Fan MM; Fan J; Shehadeh J; Zhang LY; Graham RK; Hayden MR; Raymond LA
J Neurosci; 2008 Nov; 28(48):12725-35. PubMed ID: 19036965
[TBL] [Abstract][Full Text] [Related]
7. Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease.
Fan MM; Fernandes HB; Zhang LY; Hayden MR; Raymond LA
J Neurosci; 2007 Apr; 27(14):3768-79. PubMed ID: 17409241
[TBL] [Abstract][Full Text] [Related]
8. Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity.
Khoshnan A; Ko J; Watkin EE; Paige LA; Reinhart PH; Patterson PH
J Neurosci; 2004 Sep; 24(37):7999-8008. PubMed ID: 15371500
[TBL] [Abstract][Full Text] [Related]
9. Selective degeneration in YAC mouse models of Huntington disease.
Van Raamsdonk JM; Warby SC; Hayden MR
Brain Res Bull; 2007 Apr; 72(2-3):124-31. PubMed ID: 17352936
[TBL] [Abstract][Full Text] [Related]
10. Expanded huntingtin activates the c-Jun terminal kinase/c-Jun pathway prior to aggregate formation in striatal neurons in culture.
Garcia M; Charvin D; Caboche J
Neuroscience; 2004; 127(4):859-70. PubMed ID: 15312898
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by PP1 and PP2A.
Metzler M; Gan L; Mazarei G; Graham RK; Liu L; Bissada N; Lu G; Leavitt BR; Hayden MR
J Neurosci; 2010 Oct; 30(43):14318-29. PubMed ID: 20980587
[TBL] [Abstract][Full Text] [Related]
12. Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease.
Li L; Murphy TH; Hayden MR; Raymond LA
J Neurophysiol; 2004 Nov; 92(5):2738-46. PubMed ID: 15240759
[TBL] [Abstract][Full Text] [Related]
13. Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease.
Li L; Fan M; Icton CD; Chen N; Leavitt BR; Hayden MR; Murphy TH; Raymond LA
Neurobiol Aging; 2003 Dec; 24(8):1113-21. PubMed ID: 14643383
[TBL] [Abstract][Full Text] [Related]
14. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion.
Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S
J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195
[TBL] [Abstract][Full Text] [Related]
15. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.
Zeron MM; Hansson O; Chen N; Wellington CL; Leavitt BR; Brundin P; Hayden MR; Raymond LA
Neuron; 2002 Mar; 33(6):849-60. PubMed ID: 11906693
[TBL] [Abstract][Full Text] [Related]
16. Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin.
Chen N; Luo T; Wellington C; Metzler M; McCutcheon K; Hayden MR; Raymond LA
J Neurochem; 1999 May; 72(5):1890-8. PubMed ID: 10217265
[TBL] [Abstract][Full Text] [Related]
17. Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death.
Roze E; Betuing S; Deyts C; Marcon E; Brami-Cherrier K; Pagès C; Humbert S; Mérienne K; Caboche J
FASEB J; 2008 Apr; 22(4):1083-93. PubMed ID: 18029446
[TBL] [Abstract][Full Text] [Related]
18. DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates.
Illuzzi J; Yerkes S; Parekh-Olmedo H; Kmiec EB
J Neurosci Res; 2009 Feb; 87(3):733-47. PubMed ID: 18831068
[TBL] [Abstract][Full Text] [Related]
19. Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model.
Jarabek BR; Yasuda RP; Wolfe BB
Brain; 2004 Mar; 127(Pt 3):505-16. PubMed ID: 14662521
[TBL] [Abstract][Full Text] [Related]
20. Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease.
Shehadeh J; Fernandes HB; Zeron Mullins MM; Graham RK; Leavitt BR; Hayden MR; Raymond LA
Neurobiol Dis; 2006 Feb; 21(2):392-403. PubMed ID: 16165367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
